Covered recipient · General Payments record
AMER ZEIDAN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2023 · Entire year
$115,857.62
43 records · 0 disputed
Other CMS categories — not shown on this page
Research Payments
CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2023 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $105,636.50 | 20 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,650.00 | 1 |
| Travel and Lodging | $2,497.69 | 5 |
| Food and Beverage | $1,045.93 | 16 |
| Honoraria | $1,027.50 | 1 |
By paying entity
PY2023 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BioCryst Pharmaceuticals, Inc. | $32,275.00 | 1 |
| TAIHO ONCOLOGY, INC. | $15,080.00 | 2 |
| Daiichi Sankyo Inc. | $12,241.26 | 7 |
| Sumitomo Pharma America, Inc. | $10,793.00 | 3 |
| E.R. Squibb & Sons, L.L.C. | $8,466.26 | 6 |
| Epizyme, Inc. | $8,400.00 | 1 |
| Hikma Pharmaceuticals USA | $6,540.00 | 3 |
| AbbVie Inc. | $6,412.50 | 2 |
| Boehringer Ingelheim International GmbH | $6,290.00 | 2 |
| Gilead Sciences, Inc. | $3,220.51 | 3 |
| Amgen Inc. | $2,250.00 | 1 |
| Agios Pharmaceuticals, Inc. | $1,448.33 | 3 |
| Celgene Corporation | $1,143.91 | 5 |
| Rigel Pharmaceuticals, Inc. | $1,027.50 | 1 |
| Novartis Pharmaceuticals Corporation | $129.76 | 1 |
| Astellas Pharma US Inc | $109.81 | 1 |
| Genentech USA, Inc. | $29.78 | 1 |
Payment records · PY2023
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30
43 matching records · $115,857.62 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 1–43 of 43.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc. | $2,812.50 | 12/20/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1006611111 | CMS |
| Daiichi Sankyo Inc. | $521.50 | 12/08/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1006604177 | CMS |
| Daiichi Sankyo Inc. | $44.80 | 12/08/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1006604285 | CMS |
| Daiichi Sankyo Inc. | $49.96 | 12/08/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1006604725 | CMS |
| Taiho Oncology, Inc. | $80.00 | 12/08/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1062123427 | CMS |
| Agios Pharmaceuticals, Inc. | $41.55 | 12/07/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056206189 | CMS |
| Agios Pharmaceuticals, Inc. | $106.78 | 12/07/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056213271 | CMS |
| E.R. Squibb & Sons, L.L.C. | $9.22 | 12/07/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1061065555 | CMS |
| Sumitomo Pharma America, Inc. | $3,293.00 | 10/19/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1030711951 | CMS |
| Boehringer Ingelheim International GmbH | $1,480.00 | 09/15/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017332541 | CMS |
| Sumitomo Pharma America, Inc. | $3,750.00 | 09/14/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1030711947 | CMS |
| Sumitomo Pharma America, Inc. | $3,750.00 | 08/17/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1030711943 | CMS |
| Daiichi Sankyo Inc. | $5,250.00 | 08/16/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1006611933 | CMS |
| Daiichi Sankyo Inc. | $375.00 | 08/16/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1006611999 | CMS |
| Daiichi Sankyo Inc. | $3,187.50 | 08/16/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1006613927 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,422.00 | 08/08/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016150415 | CMS |
| E.R. Squibb & Sons, L.L.C. | $9.63 | 07/28/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016150355 | CMS |
| E.R. Squibb & Sons, L.L.C. | $316.41 | 07/28/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016150361 | CMS |
| E.R. Squibb & Sons, L.L.C. | $3,806.00 | 07/27/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016150351 | CMS |
| TAIHO ONCOLOGY, INC. | $15,000.00 | 07/27/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1055235323 | CMS |
| BioCryst Pharmaceuticals, Inc. | $32,275.00 | 07/18/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1012563443 | CMS |
| Boehringer Ingelheim International GmbH | $4,810.00 | 07/17/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017332543 | CMS |
| Celgene Corporation | $133.35 | 07/14/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016150421 | CMS |
| Celgene Corporation | $30.00 | 07/14/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016150427 | CMS |
| Celgene Corporation | $10.78 | 07/14/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016150433 | CMS |
| Celgene Corporation | $359.84 | 07/14/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016150439 | CMS |
| Celgene Corporation | $609.94 | 07/14/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016150445 | CMS |
| Epizyme, Inc. | $8,400.00 | 07/14/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 981307491 | CMS |
| Gilead Sciences, Inc. | $3,160.00 | 07/10/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1035500933 | CMS |
| AbbVie Inc. | $4,050.00 | 06/08/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999842065 | CMS |
| AbbVie Inc. | $2,362.50 | 06/08/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 999842073 | CMS |
| Gilead Sciences, Inc. | $39.22 | 06/08/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1025538397 | CMS |
| Gilead Sciences, Inc. | $21.29 | 06/08/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1025770553 | CMS |
| Agios Pharmaceuticals, Inc. | $1,300.00 | 05/24/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1056212451 | CMS |
| Hikma Pharmaceuticals USA | $5,650.00 | 05/12/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053755081 | CMS |
| Hikma Pharmaceuticals USA | $690.00 | 05/12/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053755083 | CMS |
| Hikma Pharmaceuticals USA | $200.00 | 05/12/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053755085 | CMS |
| Rigel Pharmaceuticals, Inc. | $1,027.50 | 04/26/2023 | Honoraria | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1033376163 | CMS |
| Astellas Pharma US Inc | $109.81 | 04/20/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1034068205 | CMS |
| Genentech USA, Inc. | $29.78 | 02/26/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1040292195 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1,903.00 | 02/07/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1016150291 | CMS |
| Novartis Pharmaceuticals Corporation | $129.76 | 01/20/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 993257099 | CMS |
| Amgen Inc. | $2,250.00 | 01/05/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1020816239 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Cite this record.
Permalink https://industrypayments.org/provider/npi-1083819528
- Plain
- AMER ZEIDAN, NPI 1083819528. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1083819528.
- APA 7
- IndustryPayments. (2026). AMER ZEIDAN, NPI 1083819528 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1083819528
- Bluebook
- AMER ZEIDAN, NPI 1083819528, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1083819528.
Source: Centers for Medicare & Medicaid Services, Open Payments.